Healthie, the API-first infrastructure platform powering next-generation virtual care, today announced the launch of Healthie Dev Assist , an AI-integrated developer assistant that enables health tech ...

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

With a market cap of $681.8 billion, Eli Lilly and Company (LLY) is a leading global pharmaceutical company focused on ...

Choosing dividend stocks is not only about looking at the yield but also ensuring that the company pays regular dividends, has a high dividend growth ratio and the payment is sustainable based on the ...

Cadinha & Co. dramatically reduced its Johnson & Johnson holdings by 87.2% last quarter, slashing shares from 124,998 to ...

Pasritamig, a first-in-class bispecific T-cell-engaging antibody, shows potential in mCRPC with outpatient dosing designed for the community setting ...

US-based pharmaceutical company Johnson & Johnson has reported data from a Phase I trial of its bispecific antibody, ...

Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, today announced the launch of the KINCISE 2tm Surgical Automated System, a next-generation automated power tool4,7 ...

Teva starts IND-enabling studies for BD9, a dual-target therapy for asthma and atopic dermatitis, under license from Biolojic ...

In 1989, Johnson & Johnson sold its talc subsidiary. Instead of taking the opportunity to transition Johnson’s Baby Powder ...